| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.4M | — | +247.3% |
| R&D Expense | $9.6M | — | -23.5% |
| SG&A Expense | $6.6M | — | -16.4% |
| Operating Income | -$7.8M | — | +58.5% |
| Pre-tax Income | -$7.3M | — | +60.3% |
| Income Tax | $442K | — | +517.0% |
| Net Income | -$7.7M | — | +57.7% |
| EPS (Basic) | -$0.06 | — | +64.7% |
| EPS (Diluted) | -$0.06 | — | +64.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $29.0M | +13.8% | +166.7% |
| Accounts Receivable | $12.6M | +71.0% | +95.1% |
| Inventory | $920K | +11.8% | — |
| Current Assets | $65.1M | -0.3% | +21.6% |
| Total Assets | $293.6M | -2.4% | -4.1% |
| Current Liabilities | $13.6M | -16.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.9M | — | +69.0% |
| Capital Expenditures | $167K | — | -20.1% |
| Investing Cash Flow | $8.4M | — | +1060.8% |
| Financing Cash Flow | $0 | — | -100.0% |
| Free Cash Flow | -$5.1M | — | +68.4% |
| +18.9% |
| Total Liabilities | $31.0M | -8.5% | -5.1% |
| Stockholders' Equity | $262.6M | -1.6% | -4.0% |